...
首页> 外文期刊>Intensive care medicine >Time course of central venous-to-arterial carbon dioxide tension difference in septic shock patients receiving incremental doses of dobutamine
【24h】

Time course of central venous-to-arterial carbon dioxide tension difference in septic shock patients receiving incremental doses of dobutamine

机译:接受递增剂量多巴酚丁胺的败血性休克患者中心静脉-动脉二氧化碳张力差异的时程

获取原文
获取原文并翻译 | 示例

摘要

Purpose: To assess the time course of the central venous-arterial carbon dioxide tension difference (ΠPCO2) - as an index of the carbon dioxide production (VCO2)/cardiac index (CI) ratio - in stable septic shock patients receiving incremental doses of dobutamine. Methods: Twenty-two hemodynamically stable septic shock patients with no signs of global tissue hypoxia, as testified by normal blood lactate levels, were prospectively included. A dobutamine infusion was administered at a dose of up to 15 μg/kg/min in increments of 5 μg/kg/min every 30 min. Complete hemodynamic and gas measurements were obtained at baseline, and at each dose of dobutamine. Results: Dobutamine induced a significant dose-dependent increase of CI from 0 to 15 μg/kg/min (P 0.001). Oxygen consumption (VO2) and VCO2 were progressively increased by dobutamine. These increases were more marked between 10 and 15 μg/kg/min (8.3 and 8.6 %, respectively) than between the lower doses. ΠPCO2 and oxygen extraction (EO 2) significantly decreased between 0 (8.0 ± 2.0 mmHg and 43.8 ± 13.4 %, respectively) and 10 μg/kg/min of dobutamine (4.2 ± 1.6 mmHg and 28.9 ± 7.9 %, respectively), but remained unchanged from 10 to 15 μg/kg/min (5.4 ± 2.4 mmHg and 29.5 ± 8.2 %, respectively). The central venous oxygen saturation significantly (ScvO 2) increased from 0 to 10 μg/kg/min and remained unchanged from 10 to 15 μg/kg/min. Time courses of ΠPCO2, ScvO2, and EO2 were linked therefore to the biphasic changes of VO2 and VCO2. Conclusion: ΠPCO2 is a good indicator of the change of VCO2 induced by dobutamine. Measurement of ΠPCO 2, along with ScvO2 and EO2, may be presented as a useful tool to assess the adequacy of oxygen supply versus metabolic and oxygen demand.
机译:目的:评估稳定的脓毒症休克患者接受递增剂量多巴酚丁胺的中心静脉-动脉二氧化碳张力差(ΠPCO2)的时程-作为二氧化碳产生量(VCO2)/心脏指数(CI)比的指标。方法:前瞻性纳入22名血液动力学稳定的败血性休克患者,这些患者无正常组织缺氧的迹象,正常血乳酸水平可证明这一点。多巴酚丁胺输注的剂量最高为15μg/ kg / min,每30分钟以5μg/ kg / min的增量递增。在基线和每种剂量的多巴酚丁胺下均可获得完整的血液动力学和气体测量结果。结果:多巴酚丁胺诱导CI从0到15μg/ kg / min的剂量依赖性显着增加(P <0.001)。多巴酚丁胺逐渐增加了氧气消耗(VO2)和VCO2。与在较低剂量之间相比,在10和15μg/ kg / min(分别为8.3和8.6%)之间的增加更为明显。 ΠPCO2和氧气萃取(EO 2)在0(分别为8.0±2.0 mmHg和43.8±13.4%)和10μg/ kg / min的多巴酚丁胺之间分别显着降低(分别为4.2±1.6 mmHg和28.9±7.9%),但仍然存在从10到15μg/ kg / min不变(分别为5.4±2.4 mmHg和29.5±8.2%)。中心静脉血氧饱和度(ScvO 2)从0增至10μg/ kg / min,并保持不变,从10增至15μg/ kg / min。 ΠPCO2,ScvO2和EO2的时程与VO2和VCO2的双相变化有关。结论:ΠPCO2是多巴酚丁胺诱导的VCO2变化的良好指标。可以将ΠPCO2以及ScvO2和EO2的测量作为评估氧气供应与代谢和氧气需求的充足性的有用工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号